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trafﬁckingCoronaviruses are enveloped RNA viruses that generally cause mild disease in humans. However, the
recently emerged coronavirus that caused severe acute respiratory syndrome (SARS-CoV) is the most
pathogenic human coronavirus discovered to date. The SARS-CoV spike (S) protein mediates virus entry by
binding cellular receptors and inducing fusion between the viral envelope and the host cell membrane.
Coronavirus S proteins are palmitoylated, which may affect function. Here, we created a non-palmitoylated
SARS-CoV S protein by mutating all nine cytoplasmic cysteine residues. Palmitoylation of SARS-CoV S was
required for partitioning into detergent-resistant membranes and for cell–cell fusion. Surprisingly, however,
palmitoylation of S was not required for interaction with SARS-CoV M protein. This contrasts with the
requirement for palmitoylation of mouse hepatitis virus S protein for interaction with M protein and may
point to important differences in assembly and infectivity of these two coronaviruses.The Johns Hopkins University
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), machamer@jhmi.edu
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Coronaviruses are enveloped positive strand RNA viruses that
infect many avian and mammalian species, including humans. These
viruses target a variety of tissues and generally cause mild disease. In
humans, coronaviruses are responsible for approximately 20% of
common cold cases (Larson et al., 1980). However, in 2002, a novel
human coronavirus, severe acute respiratory syndrome coronavirus
(SARS-CoV), emerged in the Guangdong Province of China (Kuiken et
al., 2003; Rota et al., 2003). SARS-CoV is unlike any other human
coronavirus to date, causing severe respiratory disease and death in
10% of infected patients (WHO, 2003).
While many enveloped viruses assemble at the plasmamembrane,
coronaviruses assemble intracellularly and bud into the lumen of the
endoplasmic reticulum Golgi intermediate compartment (ERGIC)
(Klumperman et al., 1994). To produce infectious virus, the envelope
proteins must be targeted to the ERGIC for virus assembly. Many
coronavirus envelope proteins localize near the assembly site when
exogenously expressed alone (Corse and Machamer, 2000; Klumper-
man et al., 1994); however, others rely on lateral interactions withother envelope proteins to localize to the virus assembly site (McBride
et al., 2007; Nguyen and Hogue, 1997; Opstelten et al., 1995). Like
other coronaviruses, SARS-CoV encodes 3 envelope proteins, spike
(S), envelope (E) and membrane (M) (Marra et al., 2003; Rota et al.,
2003). The S protein is the secondmost abundant protein in the virion
envelope. It is a type-I membrane protein that determines host cell
tropism and is responsible for virus–cell as well as cell–cell fusion
(Cavanagh, 1995; Gallagher and Buchmeier, 2001). The SARS-CoV S
glycoprotein is large (approximately 180 kDa) and heavily glycosy-
lated with 23 potential N-linked glycosylation sites (Marra et al.,
2003; Rota et al., 2003). The cytoplasmic tail of the SARS-CoV S is
palmitoylated (Petit et al., 2007) and contains a weak endoplasmic
reticulum retrieval signal that helps it localize to the virus assembly
site when co-expressed with SARS-CoV M (McBride et al., 2007). The
M protein is the most abundant protein in the virion envelope. M can
form homo-oligomers and acts as a scaffold for virus assembly,
interacting with S, E and the viral nucleocapsid (de Haan et al., 2000;
Hogue and Machamer, 2008). SARS-CoV M has an N-linked glycosyl-
ation site, three transmembrane domains and a long cytoplasmic tail
(Voss et al., 2006). The E protein is the least abundant protein in the
virion envelope although it has an important role in virion budding
and release (DeDiego et al., 2007; Fischer et al., 1998; Kuo and
Masters, 2003; Machamer and Youn, 2006; Ortego et al., 2007, 2002).
Although the topology and glycosylation of SARS-CoV E is controver-
sial, it has a single hydrophobic domain and is palmitoylated on its
cytoplasmic tail (reviewed in (Liu et al., 2007).
Fig. 1. SARS-CoV S palmitoylation can occur in a pre-medial Golgi compartment and is a
stable modiﬁcation. (A) At 24 h post-transfection, HEK293T cells expressing SARS-CoV
S were labeled with 35S-methionine/cysteine or 3H-palmitic acid for 30 min. After lysis,
S protein was immunoprecipitated, denatured, digested with endo H, separated by
SDS–PAGE and imaged by ﬂuorography. (B) At 24 h post-transfection, HEK293T cells
expressing SARS-CoV S were labeled with 35S-methionine/cysteine or 3H-palmitic acid
for 30 min and chased for 0, 40, 80 or 120 min. After lysis, S protein was
immunoprecipitated, separated by SDS–PAGE and analyzed by ﬂuorography for 24 h
(35S) or for 1 wk (3H).
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tion that occurs on cytoplasmic cysteine residues. Protein palmitoyla-
tion occurs by the addition of the fatty acid palmitate to a protein via a
thioester linkage (Resh, 2006a). Protein palmitoylation can greatly
increase the hydrophobicity of a protein, which can in turn affect
protein activity. Transmembrane proteins are commonly palmitoy-
lated on cysteine residues that are at or near the lipid bilayer (Resh,
2006a). Cytoplasmic proteins can also be palmitoylated, inducing
membrane association (Greaves and Chamberlain, 2007). Palmitoyla-
tion is generally reversible and can be highly dynamic (Linder and
Deschenes, 2007). Addition of palmitate to proteins can greatly
inﬂuence a protein's trafﬁcking, stability, localization and interaction
with other proteins (Delandre et al., 2009;McCormick et al., 2008; Van
Itallie et al., 2005). Because of the great versatility of protein
palmitoylation, it can be used to dynamically regulate protein function
(Baker et al., 2003; Iwanaga et al., 2009).
Palmitoylation of viral proteins can play an important role in virus
assembly and infection (Grantham et al., 2009; Majeau et al., 2009;
Rousso et al., 2000). The S and E proteins of several coronaviruses
have been shown to be palmitoylated (Boscarino et al., 2008; Corse
and Machamer, 2002; Liao et al., 2006; Lopez et al., 2008; Petit et al.,
2007; Thorp et al., 2006); however, not much is known about the role
of this modiﬁcation. Coronavirus S protein palmitoylation appears to
be important for cell–cell fusion (Petit et al., 2007), infectivity and
virus assembly (Thorp et al., 2006). In addition, for mouse hepatitis
virus (MHV), it has been shown that S protein palmitoylation is
important for interaction with the M protein (Thorp et al., 2006).
Coronavirus E protein palmitoylation is important for E protein
stability, virus assembly and production (Boscarino et al., 2008; Lopez
et al., 2008). Although many important roles for palmitoylation of
coronavirus envelope proteins have been suggested, few studies have
analyzed all of the possible palmitoylated cysteine residues with
regard to function (Petit et al., 2007). Pharmacological inhibition of
palmitoylation is commonly used (Thorp et al., 2006), although this
has deleterious effects on general cellular functions since palmitoyla-
tion is a common modiﬁcation (Mikic et al., 2006; Resh, 2006b).
In this study, we addressed the role of SARS-CoV S protein
palmitoylation without the use of general palmitoylation inhibitors
by mutating the 9 potentially palmitoylated cytoplasmic cysteine
residues.We show that palmitoylation is not necessary for SARS-CoV S
protein stability, localization and trafﬁcking. We conﬁrm previous
reports that suggest a role for SARS-CoV S protein palmitoylation in
cell–cell fusion and also provide evidence for the importance of
palmitoylation in SARS-CoV S partitioning into detergent-resistant
membranes (DRMs). Importantly, we show that SARS-CoV S palmi-
toylation is not necessary for efﬁcient interaction with SARS-CoV M,
which differs frompublished experiments forMHV(Thorp et al., 2006)
and suggests a signiﬁcant difference between the two viruses thatmay
have important implications for virus assembly and infectivity.
Results
SARS-CoV S palmitoylation can occur in a pre-medial Golgi compartment
and is a stable modiﬁcation
Results from other labs have shown that coronavirus spike
proteins are palmitoylated (Bos et al., 1995; Petit et al., 2007);
however, there is no information about the compartment in which
this post-translational modiﬁcation occurs. Since the protein acyl-
transferases responsible for protein palmitoylation are localized
throughout the entire secretory pathway (Tsutsumi et al., 2008), it
is possible that coronavirus spike proteins could be palmitoylated at
the ER, Golgi or the plasma membrane. After glycoproteins are
synthesized, their sugars become modiﬁed as the protein trafﬁcs
through the secretory pathway. In the medial Golgi, glycoproteins
become resistant to digestion with endoglycosidase H (endo H)(Herscovics, 1999). To determine if SARS-CoV S becomes palmitoy-
lated in a pre-medial Golgi compartment, HEK293T cells exogenously
expressing SARS-CoV S were labeled for 30 min with 35S-methionine/
cysteine to measure total protein expression or 3H-palmitic acid to
measure palmitoylated protein. While 35S-methionine/cysteine labels
newly translated proteins, 3H-palmitic acid labels both newly made
and pre-existing proteins. After radiolabeled cells were lysed, S
protein was immunoprecipitated, denatured and digested with endo
H. As expected, upon endo H treatment, there was a population of
newly made 35S-labeled S protein that had not yet trafﬁcked past the
medial Golgi and was thus sensitive to endo H digestion (Fig. 1A, left).
There was also a population of 3H-palmitic acid labeled S protein that
was sensitive to digestion with endo H (Fig. 1A, right), indicating that
S can be palmitoylated before it trafﬁcs through the Golgi en route to
the plasma membrane. This result suggests that at least a portion of
SARS-CoV S is palmitoylated in a pre-medial Golgi compartment but
does not rule out the possibility of additional palmitoylation in a post-
medial Golgi compartment.
Palmitoylation is reversible and proteins can be palmitoylated and
de-palmitoylated rapidly (Linder and Deschenes, 2007). Generally,
viral proteins are stably palmitoylated, but there are examples of
proteins containing palmitate chains that are rapidly turned over
(Rocks et al., 2005). To determine if SARS-CoV S palmitoylation was a
stable or dynamic modiﬁcation, we performed a pulse-chase assay.
HEK293T cells expressing SARS-CoV S were pulse labeled with 35S-
methionine/cysteine or 3H-palmitic acid and chased for various times.
The 3H-palmitate label (Fig. 1B, right) was similar in stability to the
total 35S-methionine/cysteine labeled population (Fig. 2, left). This
suggests that palmitoylation of SARS-CoV S is a stable post-
translational modiﬁcation.
Construction of a palmitoylation-null SARS-CoV S
Like other coronaviruses spike proteins, SARS-CoV S has multiple
cysteine residues in its cytoplasmic tail that could be palmitoylated.
SARS-CoV S, like MHV S, has 9 cytoplasmic cysteines that are putative
palmitoylation sites (Fig. 2A) (Petit et al., 2007). To determine the role
of SARS-CoV S palmitoylation, we mutated all 9 of the cytoplasmic
cysteine residues to alanines. To ensure that the mutant SARS-CoV S
was not palmitoylated, we radiolabeled HEK293T cells expressing
wild-type or mutant S with 35S-methionine/cysteine or 3H-palmitic
acid. While wild-type and mutant SARS-CoV S proteins were
expressed at similar levels, only wild-type SARS-CoV S was
Fig. 2. SARS-CoV S lacking all cytoplasmic cysteines is not palmitoylated. (A) Cytoplasmic tail sequence of SARS-CoV S and a mutant lacking all 9 cytoplasmic cysteines (SARS-CoV
SPN). (B) At 24 h post-transfection, HEK293T cells expressing SARS-CoV S or SPN were labeled with 35S-methionine/cysteine or 3H-palmitic acid for 30 min. After lysis, S protein was
immunoprecipitated, separated by SDS–PAGE and analyzed by ﬂuorography. Longer exposure (6 weeks) of the 3H-palmitate labeled samples conﬁrmed the absence of palmitoylated
SARS-CoV SPN.
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null SARS-CoV S (SARS-CoV SPN).SARS-CoV S and SARS-CoV SPN have similar half-lives
Protein palmitoylation can have dramatic effects on protein
turnover. Palmitoylation often increases protein stability (Ochsen-
enbauer-Jambor et al., 2001); in support of this, MHV E palmitoylation
was reported to increase its half-life (Lopez et al., 2008). To determine
if palmitoylation affects the stability of S, we calculated the half-lives
of SARS-CoV S and SPN. HEK293T cells expressing SARS-CoV S or SPN
were pulse labeled and chased for various times. Wild-type and
mutant S proteins were immunoprecipitated and analyzed. The
percentage of protein remaining relative to the zero chase time was
calculated for each time of chase. Both SARS-CoV S and SPN had similar
half-lives of approximately 2.75 h (Fig. 3). This result suggests thatFig. 3. SARS-CoV S and SARS-CoV SPN have similar half-lives. At 24 h post-transfection,
HEK293T cells expressing SARS-CoV S (solid line) or SPN (dashed line) were labeled
with 35S-methionine/cysteine for 20 min and chased for 0, 1, 2 or 3 h. After lysis, S
protein was immunoprecipitated, separated by SDS–PAGE and analyzed by autoradi-
ography. Percentage of S or SPN remaining at each time point was calculated using the
amount of S or SPN at 0 h chase as 100%. The average of 3 independent experiments
±SEM is shown.palmitoylation of SARS-CoV S does not affect turnover or stability
when S protein is exogenously expressed.SARS-CoV S and SARS-CoV SPN both localize to the plasma membrane at
similar levels
SARS-CoV S localizes to the plasma membrane when exogenously
expressed alone in cells (Bisht et al., 2004; Hofmann et al., 2004;
Schwegmann-Wessels et al., 2004; Simmons et al., 2004). Transmem-
brane protein trafﬁcking as well as soluble protein translocation to
membranes can both be regulated by protein palmitoylation (Resh,
2006a). In fact, palmitoylation of different cysteines on the same
protein can lead to dramatic differences in subcellular localization
(Roy et al., 2005). To determine if palmitoylation alters the subcellular
localization of SARS-CoV S, we performed indirect immunoﬂuores-
cence microscopy on HEK293T cells expressing SARS-CoV S or SPN.
HEK293T cells expressing S or SPN were ﬁxed, permeabilized and co-
stained with antibodies to SARS-CoV S and golgin-160 (a Golgi
marker). SARS-CoV S and SPN were both present throughout the
secretory pathway, with staining at the cell surface and some internal
concentration at the Golgi complex co-localizing with golgin-160
(Fig. 4A). To further assess the localization of SARS-CoV S and SPN at
the plasma membrane, we performed surface staining on non-
permeabilized cells with mouse anti-SARS-CoV S. Subsequently,
cells were washed, ﬁxed, permeabilized and then stained for total S
protein with rabbit anti-SARS-CoV S. Surface staining of intact cells
revealed that SARS-CoV S and SARS-CoV SPN were both present at the
plasma membrane (Fig. 4B). These results suggest that blocking
palmitoylation does not affect the subcellular localization of SARS-CoV
S when exogenously expressed.
Although both SARS-CoV S and SPN were present at the cell surface,
it is possible that there could be a difference in the amount of protein
at the plasma membrane at steady state if palmitoylation affects a
post-Golgi trafﬁcking step. To determine if palmitoylation affects the
steady-state levels of S protein at the plasma membrane, we
performed a cell surface biotinylation assay. HEK293T exogenously
expressing SARS-CoV S or SPN were surface biotinylated at 0 °C with a
membrane-impermeable biotinylating reagent. Biotinylated S pro-
teins were captured with streptavidin agarose resin and analyzed by
SDS–PAGE followed by Western blotting. SARS-CoV S and SPN were
Fig. 4. SARS-CoV S and SARS-CoV SPN both localize to the cell surface. (A) At 24 h post-transfection, HEK293T expressing SARS-CoV S or SPN were ﬁxed, permeabilized and co-stained
with mouse anti-SARS-CoV S and rabbit anti-golgin 160 (a Golgi marker). (B) At 24 h post-transfection, unpermeabilized HEK293T cells were stained with mouse anti-SARS-CoV S at
0 °C for 20 min to label SARS-CoV S or SPN present on the cell surface. Cells were then ﬁxed, permeabilized and co-stained with rabbit anti-SARS-CoV S to label total S protein. (A and
B) Secondary antibodies were Alexa 488-conjugated donkey anti-mouse IgG and Texas Red-conjugated donkey anti-rabbit IgG. The same ﬁeld is shown in each set of images. (C) At
24 h post-transfection, SARS-CoV S or SPN present at the plasma membrane was biotinylated with a membrane-impermeable biotinylating agent. After lysis, biotinylated S proteins
were recovered with streptavidin agarose and analyzed by SDS–PAGE and Western blotting with rabbit anti-SARS-CoV S. The graph shows quantiﬁcation from 3 independent
experiments±SEM.
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of the total protein expressed surface biotinylated at steady state
(Fig. 4C).
SARS-CoV S palmitoylation is not necessary for trafﬁcking or interaction
with SARS-CoV M
Previous data from our lab and others have shown that
coronavirus S and M proteins can interact directly (Godeke et al.,
2000; Hsieh et al., 2008; Huang et al., 2004; McBride et al., 2007;
Nguyen and Hogue, 1997; Youn et al., 2005). Palmitoylation has been
shown to regulate protein–protein interactions (Shmueli et al., 2010).
Using the palmitoylation inhibitor 2-bromopalmitate (2-BP) (Thorp
et al., 2006) or truncation analysis (Bosch et al., 2005), it has been
indirectly shown that palmitoylation of MHV S protein is necessary for
interaction with MHV M. When the SARS-CoV S protein is exoge-
nously expressed alone, it localizes to the cell surface. However, when
co-expressed with SARS-CoV M, SARS-CoV S localizes to the Golgi
complex, co-localizing with M (McBride et al., 2007). To determine if
SARS-CoV S palmitoylation is necessary for interaction with M, we
performed indirect immunoﬂuorescence microscopy. HEK293T cells
exogenously co-expressing SARS-CoV M and SARS-CoV S or SPN were
ﬁxed, permeabilized and co-stained with antibodies to SARS-CoV S
and SARS-CoV M. Upon co-expression with SARS-CoV M, S was
retained intracellularly at the Golgi complex and co-localized
completely with M (Fig. 5A). Surprisingly, SARS-CoV SPN was also
retained intracellularly at the Golgi when co-expressed with SARS-
CoV M (Fig. 5A).
Palmitoylation did not affect the steady-state localization of SARS-
CoV S when co-expressed with M by indirect immunoﬂuorescence
microscopy but might inﬂuence the trafﬁcking of S in the absence orpresence of SARS-CoV M. To determine if palmitoylation affects the
trafﬁcking of SARS-CoV S, we performed a pulse-chase assay and
measured acquisition of endo H resistance. HEK293T cells expressing
SARS-CoV S or SPN in the absence or presence of SARS-CoV M were
pulse labeled with 35S-methionine/cysteine and chased for various
times. S protein was immunoprecipitated, denatured and digested
with endo H. S and SPN had similar trafﬁcking kinetics through the
secretory pathway. After 40 min of chase, 70–80% of both SARS-CoV S
and SPNwere resistant to digestionwith endo H, implying that 70–80%
of the pulse-labeled protein had moved past the medial Golgi,
presumably en route to the plasma membrane (Fig. 5B). Interestingly,
when co-expressed with SARS-CoV M, carbohydrate processing of
both S and SPN was dramatically reduced and only 10–20% of the
labeled proteinwas resistant to endo H digestion after 40 min of chase
(Fig. 5B). Thus, both SARS-CoV S and SPN interacted with M and were
retained in a pre-medial Golgi compartment, which is consistent with
the previously published cis-Golgi localization of some coronavirus M
proteins (Swift and Machamer, 1991).
Taken together, these results and previously published in vitro
binding data (McBride et al., 2007) suggest that palmitoylation of
SARS-CoV S is not essential for interaction with SARS-CoV M. This
reveals a potentially important difference between assembly of SARS-
CoV and MHV.
SARS-CoV S palmitoylation is necessary for partitioning into
detergent-resistant membranes
One of the best known functions of protein palmitoylation is
directing incorporation into speciﬁc membrane domains that are
resistant to extraction with cold Triton X-100. Detergent-resistant
membranes (DRMs) are sometimes referred to as lipid rafts and are
Fig. 5. SARS-CoV S and SARS-CoV SPN can be retained at the Golgi by SARS-CoVM. (A) At
24 h post-transfection, HEK293T cells expressing SARS-CoV S or SPN and SARS-CoV M
were ﬁxed, permeabilized and co-stained with mouse anti-SARS-CoV and rabbit anti-
SARS-CoV M. Secondary antibodies were Alexa 488-conjugated donkey anti-mouse IgG
and Texas Red-conjugated donkey anti-rabbit IgG. (B) At 24 h post-transfection,
HEK293T cells expressing SARS-CoV S or SARS-CoV SPN were labeled with 35S-
methionine/cysteine for 20 min and chased for 0, 20 or 40 min. After lysis, S protein
was immunoprecipitated, denatured, digested with endo H, separated by SDS–PAGE
and analyzed by autoradiography. The average of 3 independent experiments±SEM is
shown.
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sphingolipids (Brown, 2006). DRMs may represent important signal-
ing centers at the plasma membrane although they can also be found
earlier in the secretory pathway at the Golgi (Simons and van Meer,
1988). MHV S is enriched in DRMs and enrichment was reduced by
treating cells with 2-BP prior to isolation (Thorp et al., 2006). To
determine if SARS-CoV S partitions into DRMs and if that partitioning
is dependent on S protein palmitoylation, we isolated DRMs by
ﬂoatation on a sucrose step gradient after cold Triton X-100
extraction. Fractions were collected and 10% of each fraction was
analyzed by SDS–PAGE andWestern blotting with antibodies to SARS-
CoV S. To identify which fractions contained DRMs, a small portion of
each fraction was spotted onto nitrocellulose and incubated with
HRP-cholera toxin B which binds to GM1, a glycolipid enriched in
DRMs (Brown, 2006). GM1 was primarily present in fraction 4 for
both samples (Fig. 6, bottom panel). SARS-CoV S was also present in
fraction 4 (Fig. 6 top panel) while SPN was completely absent from
fractions that contained DRMs (Fig. 6 middle panel). Amido Blackstaining of the membrane ensured that similar amounts of total
proteinwere present in each lane for both S and SPN (data not shown).
It is important to note that the upper fully glycosylatedmature form of
SARS-CoV S was enriched in DRMs while the immature partially
processed form of SARS-CoV S was present in the more dense
fractions. These results demonstrate that SARS-CoV S palmitoylation
is necessary for S partitioning into DRMs. Approximately 8% of total S
protein is at the plasma membrane at steady state by biotinylation
(Fig. 4C), and an average of 15% of total S is present in detergent-
resistant membranes at steady state. Thus, it is likely that all S at the
plasma membrane is present in DRMs.
SARS-CoV S palmitoylation is necessary for cell–cell fusion
A role for coronavirus S protein palmitoylation in membrane
fusion has been suggested (Bos et al., 1995; Chang et al., 2000; Petit et
al., 2007; Shulla and Gallagher, 2009). However, these studies have
either used global palmitoylation inhibitors like 2-BP, which can be
toxic to cells (Mikic et al., 2006), or only partial mutagenesis of
palmitoylated cysteines. To determine a role for SARS-CoV S
cytoplasmic cysteine residues in cell–cell fusion, we compared the
fusion activities of SARS-CoV S and SPN in Vero cells, which express the
functional SARS-CoV receptor, ACE2. Vero cells expressing SARS-CoV S
or SPN were brieﬂy trypsinized to activate the protein for fusion
(Simmons et al., 2004). The number of nuclei per syncytia (≥3 nuclei)
was counted 24 h after trypsinization. Vero cells expressing SARS-CoV
S had extensive syncytium formation with approximately 5 nuclei per
syncytia, but syncytium formation was absent in cells expressing
SARS-CoV SPN (Fig. 7). These results suggest a critical role for S protein
palmitoylation in cell–cell fusion.
In conclusion, we have shown that palmitoylation is dispensable
for the stability, subcellular localization and trafﬁcking of SARS-CoV S.
However, SARS-CoV S palmitoylation is important for partitioning
into DRMs and for cell–cell fusion. Most importantly, SARS-CoV S
palmitoylation is not important for interaction with SARS-CoV M.
SARS-CoV M retained non-palmitoylated S in the Golgi and reduced
the extent of non-palmitoylated S trafﬁcking through the secretory
pathway aswell as wild-type SARS-CoV S. These results demonstrate a
signiﬁcant difference between SARS-CoV and MHV that may have
signiﬁcant implications for virus assembly and infection.
Discussion
Protein palmitoylation is a common post-translational modiﬁca-
tion where a 16 carbon fatty acid chain is added to cysteine residues
on proteins. Palmitoylation can be dynamic and plays an important
role in regulating protein function and activity. In fact, alterations in
protein palmitoylation have been shown to affect protein stability,
trafﬁcking and subcellular localization as well as protein–protein
interactions (Linder and Deschenes, 2007; Lopez et al., 2008; Resh,
2006a; Roy et al., 2005; Thorp et al., 2006; Van Itallie et al., 2005).
Transmembrane proteins can be palmitoylated throughout the
secretory pathway and cytoplasmic proteins can be palmitoylated at
different secretory pathway membranes. Additionally, many impor-
tant regulatory proteins, signaling molecules and trafﬁcking compo-
nents have been shown to be palmitoylated (Linder and Deschenes,
2007). In line with the important role of palmitoylation in cellular
processes, global inhibition of palmitoylation has deleterious effects
on cellular function (Mikic et al., 2006; Resh, 2006b).
In addition to the palmitoylation of endogenous cellular proteins,
many viral proteins are palmitoylated. Perhaps the most well-known
examples of palmitoylated viral proteins are the inﬂuenza virus HA
and M2 proteins (Holsinger et al., 1995; Sugrue et al., 1990; Veit et al.,
1991). However, there are many more examples of viral protein
palmitoylation including those encoded by hepatitis C virus (Majeau
et al., 2009), human immunodeﬁciency virus (Rousso et al., 2000),
Fig. 6. SARS-CoV S palmitoylation is necessary for partitioning into detergent-resistant membranes. At 24 h post-transfection, detergent-resistant membranes (DRMs) were
extracted from HEK293T cells expressing SARS-CoV S or SPN using cold Triton. DRMswere isolated using discontinuous density ultracentrifugation, and fractions were collected from
the top. S protein was identiﬁed byWestern blotting (upper and middle panels) and DRMs were identiﬁed using HRP-cholera toxin B, which binds ganglioside GM1 (bottom panel).
A representative image of 3 independent experiments is shown.
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(Bos et al., 1995; Corse and Machamer, 2002; Petit et al., 2007).
Inhibition or disruption of viral protein palmitoylation can have
negative effects on important protein–protein interactions in the
virion envelope (Yu et al., 2006), virus assembly (Boscarino et al.,
2008; Lopez et al., 2008; Majeau et al., 2009; Thorp et al., 2006; Ye et
al., 2004), infectivity (Boscarino et al., 2008; Lopez et al., 2008; Rousso
et al., 2000; Yan et al., 2004), subcellular protein localization (Nozawa
et al., 2003) and even protein stability (Lopez et al., 2008).
Two of the coronavirus envelope proteins, S and E, contain
conserved palmitoylated cysteine residues in their cytoplasmic tails.
Palmitoylation of the coronavirus E protein does not seem to be
important for Golgi localization (Boscarino et al., 2008; Corse and
Machamer, 2002; Lopez et al., 2008) or virus entry (Lopez et al., 2008)
but has been implicated in protein stability and efﬁcient virus growth
(Boscarino et al., 2008; Lopez et al., 2008). E proteins have 2–3
potentially palmitoylated cytoplasmic cysteine residues. The work
performed to determine the role of coronavirus E protein palmitoyla-
tion used mutagenesis of all potentially palmitoylated cysteine
residues, which conclusively implicated or eliminated possible roles
for E protein palmitoylation. Coronavirus S proteins contain a
cysteine-rich domain in their cytoplasmic tails with at least 7 cysteine
residues (Hogue and Machamer, 2008). Coronavirus S protein
palmitoylation has been implicated in cell–cell fusion, virus–cell
fusion, virus assembly and infectivity; however, studies focusing on
the role of S protein palmitoylation have so far mutated only some of
the palmitoylated cysteines (Petit et al., 2007; Shulla and Gallagher,
2009) or used pharmacological inhibitors of protein palmitoylation
(Thorp et al., 2006). These methods and results led to only a partial
disruption of protein palmitoylation and partial phenotypes. Here, we
mutated all 9 cytoplasmic cysteine residues to conclusively determine
the role of SARS-CoV S palmitoylation.
We constructed a palmitoylation-null mutant protein, SARS-CoV
SPN, with all 9 cytoplasmic cysteine residues mutated to alanines,
which was not palmitoylated (Fig. 2). The compartment in which
envelope proteins become palmitoylated has not been determined for
any coronavirus. When SARS-CoV S was exogenously expressed in
cells, we identiﬁed a population of palmitoylated, endo H sensitive
SARS-CoV S (Fig. 1A). This suggests that at least some SARS-CoV S
protein is palmitoylated in a pre-medial Golgi compartment. MHV S
can also be palmitoylated in an early compartment (van Berlo et al.,
1987). However, it will be important to determine if S protein
palmitoylation occurs similarly during an infection when other viral
proteins are present. Also, we determined that palmitoylation of
SARS-CoV S is a relatively stable post-translational modiﬁcation
(Fig. 1B), which appears to be common among palmitoylated viral
proteins (Linder and Deschenes, 2007). This does not rule out thepossibility that different cysteines may have differential rates of
palmitate turnover; however, it does suggest that there is always a
population of S protein that is palmitoylated to some extent. Unlike
the MHV E protein, disruption of SARS-CoV S palmitoylation did not
affect the stability of the protein since SARS-CoV S and SPN had similar
half-lives when expressed exogenously (Fig. 3). However, like the E
protein, SARS-CoV S palmitoylation does not appear to be important
for subcellular localization (Fig. 4) (Boscarino et al., 2008; Corse and
Machamer, 2002; Linder and Deschenes, 2007; Lopez et al., 2008). We
conﬁrmed previous results published for MHV and SARS-CoV that S
palmitoylation is important for cell–cell fusion. However, we show a
complete inhibition of cell–cell fusion (not a partial reduction) when
cells expressed SPN (Fig. 7). This abolition of cell–cell fusion was not
due to a reduction in the amount of SARS-CoV SPN at the plasma
membrane (Fig. 4C) but possibly due to an exclusion of SARS-CoV SPN
from DRMs (Fig. 6). In fact, DRMs have been implicated in cell–cell
fusion events at the plasma membrane (Mukai et al., 2009; Teissier
and Pecheur, 2007). Although it is possible thatmutating all 9 cysteine
residues to alanines dramatically disrupted the conformation of the
SARS-CoV S protein, this seems unlikely since SPN was stable,
trafﬁcked through the secretory pathway properly (Fig. 5B), had the
correct subcellular localization and could still interact with the M
protein (Fig. 5A).
Most importantly, we show that palmitoylation of SARS-CoV S is not
necessary for interaction with the M protein. Previous results from our
lab suggested SARS-CoV S and M could interact in vitro using a
recombinant SARS-CoV S cytoplasmic tail puriﬁed from bacteria. This
recombinant S protein was not palmitoylated, yet it was able to interact
with in vitro transcribed and translated SARS-CoV M (McBride et al.,
2007). In that invitro experiment, only the tail of the SARS-CoVSprotein
was used; here we conﬁrm those results using different in vivo assays
using the full length protein. We showed that SARS-CoV M was able to
retain SPN at the Golgi complex similarly to wild-type S (Fig. 5A). Also,
SARS-CoV M was able to reduce the amount of SPN carbohydrate
processing (Fig. 5B) and the amount of SPN at the plasma membrane
(data not shown) similar towild-type SARS-CoV S. These results suggest
a signiﬁcant difference betweenMHVand SARS-CoV. ForMHV, very low
concentrations of 2-BP, which only slightly reduced the amount ofMHV
S palmitoylation, had dramatic results on the ability of MHV S to form a
complex with M. This resulted in reduced MHV S incorporation into
virions, which led to a reduction in infectious virus (Thorp et al., 2006).
MHV S appears to be extremely sensitive to changes in palmitoylation
levels, where as SARS-CoV S can better tolerate disruptions in
palmitoylation. An interesting possibility is that wild-type fully
palmitoylated S and palmitoylation-null S both interact equally well
with M, but only partially palmitoylated S protein does not interact
efﬁciently withM protein. It is also possible that an endogenous protein
Fig. 7. SARS-CoV S palmitoylation is necessary for cell–cell fusion. At 48 h post-
transfection, Vero cells expressing SARS-CoV S (A) or SARS-CoV SPN (B) were
trypsinized then re-plated. At 24 h post-trypsinization, the number of nuclei per
syncytia was counted; the average of 3 independent experiments±SEM is shown (C).
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this could have subsequently affected MHV S trafﬁcking, localization
and/or stability since none of these variables were tested after 2-BP
treatment. We attempted to use virus-like particle (VLP) production to
determine if SARS-CoV S palmitoylation was important for virus
assembly, but the ability of S and SPN to be released from membranous
vesicles when expressed alone in 293T cells precluded our ability to
determine the contribution of palmitoylation to assembly using this
assay. Our results suggest that there would be no difference between S
and SPN assembly into virions since both can interact equally well with
M; however, it is possible that spike incorporation into virions could
depend on more than interaction with M protein. Even if SARS-CoV SPN
is well incorporated into assembling virions, overall infection may be
limited by the cell–cell fusion defect seen with SPN. Also, recently
published work suggests an unexpected role for MHV S cytoplasmic
cysteine residues in virus–cell fusion (Shulla and Gallagher, 2009). Here
we examined the ability of palmitoylation-null SARS-CoV S to interact
withMwithout complications fromvirus infection; however, it will also
be important to determine the role of S protein palmitoylation in
infected cells by inserting the mutations into an infectious clone.There is no clear consensus sequence for protein palmitoylation.
Palmitate adducts at different cysteines can have different dynamics
(Linder and Deschenes, 2007) and with the large number of
potentially palmitoylated cysteines in coronavirus S proteins, there
could bemany possibilities for differential S protein regulation based
on which cysteines are palmitoylated and when. Identifying
palmitoylated SARS-CoV S cysteine residues will prove to be difﬁcult
due to the 9 potentially palmitoylated cysteines; a large number of
combinatorial cysteine mutations would have to be made to fully
uncover the role of each. Also,mutagenesis of a palmitoylated residue
could induce palmitoylation of residues that are not usuallymodiﬁed.
Although S and SPN are both present at the plasma membrane in
similar amounts, SPN is excluded from DRMs. While this is interesting,
a more important observation revolves around the amount of SARS-
CoV S at the cell surface. Based on our calculations, only 7–8% of SARS-
CoV S protein expressed in cells is present at the plasmamembrane at
steady state; however, 15% of total S is present in DRMs. This suggests
that all S present at the plasma membrane is in DRMs. Since DRMs
form in the late Golgi, it is likely that S is enriched in these domains
before trafﬁcking to the plasma membrane. It seems that corona-
viruses have evolved multiple mechanisms to control the amount and
distribution of S at the plasma membrane. These mechanisms include
ER retrieval (Lontok et al., 2004; McBride et al., 2007), endocytosis
(Lontok et al., 2004; Petit et al., 2005; Youn et al., 2005), lateral
protein–protein interactions (McBride et al., 2007; Opstelten et al.,
1995) and sequestration in DRMs (Thorp et al., 2006). It is possible
that too much S at the cell surface may compromise a productive
infection. In support of this idea, previous work in our lab where the
ER retrieval and endocytosis signals of the infectious bronchitis virus
(IBV) S protein were mutated in an infectious clone showed massive
syncytia formation early after transfection but failed to generate any
infectious virus (Youn et al., 2005). This suggests that too much S at
the plasma membrane is detrimental to infection, possibly due to
premature cell death. Anchoring in DRMs insures that any S that is
present at the plasma membrane is functional and fully fusion
competent. Thus, only small amounts of S protein at the cell surface
are required to ensure efﬁcient cell–cell fusion. It is also possible that
MHV relies heavily on S protein palmitoylation for interaction with M
because MHV S does not contain an ER retrieval signal. The SARS-CoV
S ER retrieval signal presumably increases the possibility of S-M
interaction by promoting cycling of S through the budding compart-
ment. Without this mechanism, MHV may rely on palmitoylation to
present the S protein cytoplasmic tail properly for interaction with M.
It will be interesting to determine the role of IBV S palmitoylation in
S-M interaction since IBV S contains a canonical ER retrieval signal.
In conclusion, our results suggest that SARS-CoV S palmitoylation
is important for S partitioning into DRMs and cell–cell fusion.
However, SARS-CoV S palmitoylation was not necessary for S protein
stability, trafﬁcking or subcellular localization. Additionally, we
conclude that SARS-CoV S palmitoylation is not necessary for efﬁcient
interaction with M protein, which is different from previously
published results for MHV (Thorp et al., 2006). This suggests there
are differences in the requirements for coronavirus assembly that
could translate into important differences in virus infection and
spread.Materials and methods
Cells
HEK293T and Vero cells were maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) (Invitrogen/Gibco, Grand Island, NY)
supplemented with 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA) and 0.1 mg/ml Normocin (InvivoGen, San Diego,
CA) at 37 °C and 5% CO2.
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pCAGGS/SARS-CoV S and pCAGGS/SARS-CoV M were previously
described (McBride et al., 2007). pCAGGS/SARS-CoV SPN was
generated using QuikChange (Stratgene, La Jolla, CA) site-directed
mutagenesis to introduce the following mutations sequentially into
pcDNA 3.1/SARS-CoV S: C1217A, C1218A, C1222A, C1223A, C1225A,
C1230A, C1232A, C1235A and C1236A. The mutated region of SARS-
CoV SPN was excised from pcDNA3.1 and subcloned into pCAGGS-MCS
expression vector (Niwa et al., 1991) using EcoRV and XhoI.
Transient transfections
Transient transfections were performed using Fugene6 transfec-
tion reagent (Roche, Indianapolis, IN) as per the manufacturer's
instructions. When co-expressed with SARS-CoV M, there was a
decrease in the expression level of SARS-CoV S and SPN. To counteract
this decrease, we co-transfected S and M at a 3:1 ratio. Brieﬂy, 1 day
after plating cells, 50% conﬂuent 35 mm dishes of HEK293T or Vero
cells were transfected with a total of 1.5 μg of DNA per dish when
expressing SARS-CoV S or SPN alone. When SARS-CoV S or SPN was co-
expressed with SARS-CoV M, 2μg of DNA was used per dish: 1.5μg
pCAGGS/SARS-CoV S or SPN and 0.5μg SARS-CoV M. For detergent-
resistant membrane isolation, a 60% conﬂuent 10 cm dish of HEK293T
cells was transfected with 12μg of DNA.
Antibodies
Rabbit anti-SARS-CoV S (McBride et al., 2007), rabbit anti-SARS-
CoV M (McBride et al., 2007) and rabbit anti-golgin 160 (Hicks and
Machamer, 2002) polyclonal antibodies were previously described.
Mouse anti-SARS-CoV S monoclonal antibodies were from Biodefense
and Emerging Infections (BEI) Research Resources (Manassas, VA).
Alexa 488-conjugated donkey anti-mouse IgG was from Invitrogen/
Molecular Probes (Eugene, OR), and Texas Red-conjugated donkey
anti-rabbit IgG was from Jackson ImmunoResearch (Westgrove, PA).
Horseradish peroxidase-conjugated (HRP) anti-rabbit IgG was from
Amersham/GE Healthcare (Piscataway, NJ).
Metabolic labeling and endoglycosidase H digestion
At 24 h post-transfection, HEK293T cells were pulse labeled and
chased as previously described (McBride et al., 2007). Brieﬂy, cells
were starved in methionine/cysteine-free DMEM, labeled for 20 min
with 50μCi of 35S methionine/cysteine, Expre35S35S (Perkin Elmer,
Waltham, MA) in methionine/cysteine-free DMEM per 35 mm dish
and then chased for the times indicated. Cells were lysed in detergent
solution (50 mM Tris–HCl [pH 8.0], 1% NP-40, 0.4% deoxycholate,
62.5 mM EDTA) containing protease inhibitor cocktail (Sigma, St.
Louis, MO). Lysates were clariﬁed for 10 min at 4 °C at 16,000×g and
SDS was added to a ﬁnal concentration of 0.2%. SARS-CoV S and SPN
were immunoprecipitated with rabbit anti-SARS-CoV S polyclonal
antibodies (McBride et al., 2007) overnight at 4 °C. Immune
complexes were collected at room temperature with washed
Staphylococcus aureus Pansorbin cells (Calbiochem, San Diego, CA)
and washed three times in radioimmunoprecipitation assay (RIPA)
buffer (0.1% SDS, 50 mM Tris–HCl [pH 8.0], 1% deoxycholate, 150 mM
NaCl, 1% TX-100). Samples were eluted in 1% SDS, 50 mM Tris–HCl
[pH 6.8] at 100 °C for 3 min and digested with 0.1 mU/ul endogly-
cosidase H (New England BioLabs, Beverly, MA) in 150 mM NaCitrate
[pH 5.5] overnight at 37 °C. Concentrated Laemmli sample buffer was
added for a ﬁnal concentration of 1X (50 mM Tris–HCl [pH 6.8], 2%
SDS, 20% glycerol, 0.025% bromophenol blue and 5% 2-mercaptoetha-
nol) and samples were subjected to 8% SDS–PAGE. To reduce variation
in the SARS-CoV S and SPN half-life experiment, cells were ﬁrst seeded
on a 10-cm dish. The following day, cells were transfected with 12μgof pCAGGS/SARS-CoV S or SPN. 20 h post-transfection, cells were
trypsinized and seeded onto 35 mm dishes. Cells were allowed to re-
attach for 4 h and were then labeled as described above. Labeled
proteins were visualized by Molecular Imager FX phosphoimager
(BioRad) and quantiﬁed using Quantity One software.
3H-palmitic acid labeling
At 24 h post-transfection, HEK293T cells were labeled with 3H-
palmitic acid as previously described (Corse and Machamer, 2002).
Brieﬂy, HEK293T cells were washed and incubated for 20 min in
serum-free DMEM. Cells were labeled for 30 min at 37 °C with 250 μCi
of 3H-palmitic acid ([9,10-3H(N)]-) dried under N2 and resuspended
in DMEM supplemented with 10% FBS, 50 mM Hepes [pH 7.2] and 1X
non-essential amino acids (Invitrogen/Gibco, Grand Island, NY). A
parallel dish was labeled for 30 min with 50μCi 35S-methionine/
cysteine as described above to detect total S protein. Cells were chased
for various times and lysed and immunoprecipitated as described
above. For endo H assays, samples were eluted and digested as
described above. For all other assays, samples were eluted in 1X
Laemmli sample buffer. Samples were subjected to 8% SDS–PAGE, gels
were impregnated with 2,5 diphenyloxazole (PPO) and processed by
ﬂuorography at −80 °C.
Indirect immunoﬂuorescence microscopy
HEK293T cells were prepared for indirect immunoﬂuorescence
microscopy as previously described (McBride et al., 2007). Cells were
seeded onto glass coverslips treated with 1 mg/ml poly-L-lysine, mol
wt N300,000 (Sigma, St. Louis, MO) to improve cell adherence during
processing. Brieﬂy, at 24 h post-transfection HEK293T cells were
washed in PBS and ﬁxed for 10 min in 3% paraformaldehyde in PBS.
Fixative was quenched in 10 mM glycine in PBS (PBS/gly) and cells
were permeabilized for 3 min in 0.5% TX-100 in PBS/gly. Cells were
washed in PBS/gly and co-stained with primary antibodies diluted in
1% bovine serum albumin (BSA) in PBS/gly as follows: mouse anti-
SARS-CoV S (1:100) and rabbit anti-golgin 160 (1:500), mouse anti-
SARS-CoV S (1:100) and rabbit anti-SARS-CoV S (1:400), or mouse
anti-SARS-CoV S (1:100) and rabbit anti-SARS-CoV M (1:400). Cells
were washed in PBS/gly and co-stained for 15 min with secondary
antibodies as follows: Alexa 488 donkey anti-mouse (1:500) and
Texas Red donkey anti-rabbit (1:400). Cells were washed in PBS/gly
and mounted in 0.1 M N-propylgallate in glycerol. Images were
obtained with an Axioscop microscope (Zeiss, Thornwood NJ)
equipped for epiﬂuorescence using a Sensys charge-coupled device
camera (Photometric, Tucson, AZ) and IP Lab software (Scanalytics,
Vienna, VA).
Cell surface biotinylation
Cells were seeded onto dishes treated with 1 mg/ml poly-L-lysine
mol wt N300,000 (Sigma, St. Louis, MO) to improve cell adherence
during processing. At 24 h post-transfection, HEK293T cells were
washed with PBS and biotinylated in 1 mg/ml Sulfo-NHS-LC-Biotin
(Pierce/ThermoScientiﬁc, Rockford, IL) in PBS for 30 min at 0 °C. After
washing in PBS, the biotinylation reaction was quenched for 3 min
with PBS containing 50 mM glycine. Cells were lysed in lysis buffer
(10 mM Hepes [pH 7.2], 0.2% NP-40, 150 mM NaCl) containing
protease inhibitor cocktail at 0 °C for 10 min. Lysates were clariﬁed
for 10 min at 16,000×g at 4 °C. 10% of the sample was reserved for
quantiﬁcation of total S protein. Biotinylated proteins were isolated
overnight at 4 °C using washed streptavidin agarose resin (Pierce/
ThermoScientiﬁc, Rockford, IL). Streptavidin beads were washed in
lysis buffer and biotinylated proteins were eluted in 1X Laemmli
sample buffer for 3 min at 100 °C. Samples were subjected to 8% SDS–
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(PVDF), (Millipore, Bedford,MA) for Western Blotting.
Western blotting
PVDF membranes were blocked for 30 min in 5% non-fat dry milk
in Tris buffered saline with Tween (TBST, 150 mM NaCl, 10 mM Tris–
HCl [pH 7.4], 0.05% Tween-20). Membranes were incubated overnight
at 4 °C with rabbit anti-SARS-CoV S polyclonal antibody diluted
1:5,000 in 5% non-fat dry milk made in TBST. Membranes were
washed in TBST and then incubated at room temperature for 1 h with
HRP-conjugated anti-rabbit IgG diluted 1:10,000 in 5% non-fat dry
milk made in TBST. Membranes were washed in TBST then treated
with HyGlo chemiluminescence reagent (Denville Scientiﬁc, Metu-
chen, NJ) as per the manufacturer's instructions. Membranes were
analyzed using a Versa Doc imaging station (BioRad, Hercules, CA)
and quantiﬁed using Quantity One software (BioRad).
Detergent-resistant membrane isolation
Detergent-resistant membranes (DRMs) were isolated by using
discontinuous density ultracentrifugation. At 24 h post-transfec-
tion, HEK293T cells were washed with cold PBS and lysed in 1 ml
cold 1% Triton X-100 in TNE (10 mM Tris–HCl [pH 7.4], 150 mM
NaCl, 5 mM EDTA) for 1 h at 0 °C, with occasional mixing. Ten
percent of the lysate was reserved for quantiﬁcation of total S
protein. All of the following steps were performed at 0 °C: 1 ml of
the lysate was mixed with 1 ml of 85% sucrose in TNE and placed in a
pre-cooled SW41 ultracentrifuge tube (Beckman, Palo Alto, CA),
4 ml of 35% sucrose in TNEwas overlaid on the lysate containing 85%
sucrose, 1 ml of 5% sucrose in TNE was overlaid on the 35% sucrose
and 5 ml of TNE was overlaid on the 5% sucrose. Samples were
centrifuged for 18 h at 285,000×g at 4 °C. After ultracentrifugation,
DRMs were visible ﬂoating near the 5%/35% sucrose interface. After
removal of 3.5 ml of TNE from the top of the gradient, 600-μl
fractions were collected. To identify fractions containing DRMs, 3 μl
of each fraction was dot blotted onto nitrocellulose membrane and
dried. After blocking for 30 min in 5% non-fat dry milk in TBST, the
membrane was washed in TBST and incubated for 1 h with HRP-
cholera toxin B (1:25,000) (Molecular Probes/Invitrogen) in 3% BSA
in TBST. To identify fractions containing SARS-CoV S protein, 10% of
each fraction was subjected to 8% SDS–PAGE and Western blotting
after the addition of concentrated Laemmli sample buffer to 1×.
Membranes were treated with HyGlo chemiluminescence reagent
as per the manufacturer's instructions and analyzed using a Versa
Doc imaging station.
Fusion assay
At 48 h post-transfection, Vero cells were washed with PBS, brieﬂy
trypsinized with 0.02% trypsin (Invitrogen/Gibco, Grand Island, NY)
for 3 min at room temperature and returned to 37 °C. At 24 h post-
trypsinization, the number of nuclei per syncytia was determined. A
syncytium was classiﬁed as 3 or more nuclei per cell. Data from 3
independent experiments were averaged.
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